Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models

Breast Cancer Research

Volumn 9, Issue 1, 2007, Pages

  Rajkumar, Lakshmanaswamy ^a   Kittrell, Frances S ^b   Guzman, Raphael C ^c   Brown, Powel H ^b   Nandi, Satyabrata ^c   Medina, Daniel ^b  

^a Paul L Foster School of Medicine   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; PROGESTERONE; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER RISK; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; GENE DELETION; GENE EXPRESSION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HYPERPLASIA; MOUSE; NONHUMAN; RISK ASSESSMENT; RNA ANALYSIS; TRANSGENE; TREATMENT DURATION; ANIMAL; BAGG ALBINO MOUSE; CELL TRANSFORMATION; DISEASE MODEL; EXPERIMENTAL NEOPLASM; FEMALE; GENETIC ENGINEERING; GENETICS; PHYSIOLOGY; PRECANCER; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; ESTROGENS; FEMALE; GENES, P53; GENETIC ENGINEERING; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; PRECANCEROUS CONDITIONS; PROGESTERONE;

EID: 34248231386     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1645     Document Type: Article

References (37)

1. Beaston GL On the treatment of inoperable cases of carcinoma of the mamma: Suggestions for a new method of treatment with illustrative cases Lancet 1896, ii:104-107.
2. Howell A Cuzick J Baum M Buzdar A Dowsett M Forbes JF Hoctin-Boes G Houghton J Locker GY Tobias JS ATAC Trialists' Group Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer Lancet 2005, 365:60-62. 10.1016/S0140-6736(05)74803-0 15639680
3. Willett WC Rockhill B Hawkinson SE Hunter D Colditz GA Nongenetic factors in the causation of breast cancer Diseases of the Breast Philadelphia: Lippincott, Williams & Wilkins Harris JA, Lippman ME, Morrow M, Osborne CK 3 2004, 223-276.
4. Huggins C Moon RC Morii S Extinction of experimental mammary cancer. I. Estradiol-17β and progesterone Proc Natl Acad Sci USA 1962, 48:379-386. 220788 14449778 10.1073/pnas.48.3.379
5. Sivaraman L Medina D Hormone-induced protection against breast cancer J Mammary Gland Biol Neoplasia 2002, 7:77-92. 10.1023/A:1015774524076 12160088
6. Medina D Mammary developmental fate and breast cancer risk Endocr Relat Cancer 2005, 12:483-495. 10.1677/erc.1.00804 15788636
7. Tokunaga M Land CE Tokuoka S Nishimori I Soda M Akiba S Incidence of female breast cancer among atomic bomb survivors 1950-1985 Radiation Res 1994, 138:209-223. 10.2307/3578591 8183991
8. Holtzman S Stone JP Shellabarger CJ Radiation-induced mammary carcinogenesis in virgin, pregnant, lactating, and postlactating rats Cancer Res 1982, 42:50-53. 7053866
9. Cardiff RD Mouse models of human breast cancer Comp Med 2003, 53:250-253. 12868567
10. Jerry DJ Kittrell FS Kuperwasser C Laucirica R Dickinson ES Bonilla PJ Butel JS Medina D A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development Oncogene 2000, 19:1052-1058. 10.1038/sj.onc.1203270 10713689
11. Medina D Kittrell FS Shepard A Stephens LC Jiang C Lu J Allred DC McCarthy M Ullrich RL Biological and genetic properties of the p53 null preneoplastic mammary epithelium FASEB J 2002, 16:881-883. 11967232
12. Medina D Ullrich R Meyn R Wiseman R Donehower L Environmental carcinogens and p53 tumor suppressor gene interactions in a transgenic mouse model for mammary carcinogenesis Environ Mol Mutagen 2002, 39:178-183. 10.1002/em.10064 11921187
13. Hu Y Sun H Drake J Kittrell F Abba MC Deng L Gaddis S Sahin A Baggerly K Medina D Aldaz CM From mice to humans: Identification of commonly deregulated genes in mammary cancer via comparative SAGE studies Cancer Res 2004, 64:7748-7755. 10.1158/0008-5472.CAN-04-1827 15520179
14. Muller WJ Sinn E Pattengale PK Walace R Leder P Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene Cell 1988, 54:105-115. 10.1016/0092-8674(88)90184-5 2898299
15. Guy CT Webster MA Schaller M Parsons TJ Cardiff RD Muller WJ Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease Proc Natl Acad Sci USA 1992, 89:10578-10582. 50384 1359541 10.1073/pnas.89.22.10578
16. Anisimov VN Popovich IG Alimova IN Zabezhinski MA Semenchenko AV Yashin AI Number of pregnancies and ovariectomy modify mammary carcinoma development in transgenic HER-2/neu female mice Cancer Lett 2003, 193:49-55. 10.1016/S0304-3835(02)00721-8 12691823
17. Said TK Conneely O Medina D O'Malley BW Lydon JP Progesteronem, in addition to estrogen, induces cyclin D1 expression in mammary epithelial cells in vivo J Endocrinology 1997, 138:3933-3939. 10.1210/en.138.9.3933
18. Medina D Kittrell FS Hill J Shepard A Thordarson G Brown P Tamoxifen inhibition of estrogen receptor-α-negative mouse mammary tumorigenesis Cancer Res 2005, 65:3493-3496. 15833886
19. Rajkumar L Guzman RC Yang J Thordarson G Talamantes F Nandi S Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis Proc Natl Acad Sci USA 2001, 98:11755-11759. 58802 11573010 10.1073/ pnas.201393798
20. Bouchard L Lamarre L Tremblay PJ Jolicoeur P Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene Cell 1989, 57;931-936. 10.1016/0092-8674(89)90331-0 2567634
21. Sivaraman L Stephens LC Markaverich BM Clark JA Krnacik S Conneely OM O'Malley BW Medina D Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats Carcinogenesis 1998, 19:1573-1581. 10.1093/carcin/19.9.1573 9771927
22. Guzman RC Yang J Rajkumar L Thordarson G Chen X Nandi S Hormonal prevention of breast cancer: Mimicking the protective effect of pregnancy Proc Natl Acad Sci USA 1999, 96:2520-2525. 26817 10051675 10.1073/pnas.96.5.2520
23. Reddy M Nguyen S Farjamrad F Laxminarayan S Rajkumar J Guzman RC Yang J Nandi S Short-term hormone treatment with pregnancy levels of estradiol prevents mammary carcinogenesis by preventing promotion of carcinogen-initiated cells Proceedings of the 93rd American Association for Cancer Research Annual Meeting: 6-10 April, 2002; San Francisco, CA 43:824.
24. Thordarson G Jin E Guzman RC Swanson SM Nandi S Talamantes F Refractoriness to mammary tumorigenesis in parous rats: Is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia? Carcinogenesis 1995, 16:2847-2853. 10.1093/carcin/16.11.2847 7586208
25. Abrams TJ Guzman RC Swanson SM Thordarson G Talamantes F Nandi S Changes in the parous rat mammary gland environment are involved in parity-associated protection against mammary carcinogenesis Anticancer Res 1998, 18:4115-4121. 9891455
26. Barcellos-Hoff MH Ravani SA Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells Cancer Res 2000, 60:1254-1260. 10728684
27. Maffini MV Soto AM Calabro JM Ucci AA Sonnenschein C The stroma as a crucial target in rat mammary gland carcinogenesis J Cell Sci 2004, 117:1495-1502. 10.1242/jcs.01000 14996910
28. Schedin P Mitrenga T McDaniel S Kaeck KM Mammary ECM composition and function are altered by reproductive state Mol Carcinog 2004, 41:207-220. 10.1002/mc.20058 15468292
29. Rajkumar L Guzman RC Yang J Thordarson G Talamantes F Nandi S Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments Breast Cancer Res 2004, 6:R31-R37. 314450 14680498 10.1186/ bcr734
30. Swanson SM Guzman RC Collins G Tafoya P Thordarson G Talamantes F Nandi S Refractoriness to mammary carcinogenesis in the parous mouse is reversible by hormonal stimulation induced by pituitary isografts Cancer Lett 1995, 90:171-181. 10.1016/0304-3835(95)03712-6 7736453
31. Thordarson G Van Horn K Guzman RC Nandi S Talamantes F Parous rats regain high susceptibility to chemically induced mammary cancer after treatment with various mammotropic hormones Carcinogenesis 2001, 22:1027-1033. 10.1093/carcin/22.7.1027 11408345
32. Ginger MR Gonzalez-Rimbau MF Gay JP Rosen JM Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland Mol Endocrinol 2001, 15:1993-2009. 10.1210/me.15.11.1993 11682629
33. Ginger MR Rosen JM Pregnancy-induced changes in cell-fate in the mammary gland Breast Cancer Res 2003, 5;192-197. 165015 12817990 10.1186/bcr603
34. Thordarson G Semaan S Low C Ochoa D Leong H Rajkumar L Guzman RC Nandi S Talamantes F Mammary tumorigenesis in growth hormone deficient spontaneous dwarf rats; effects of hormonal treatments Breast Cancer Res Treat 2004, 87:277-290. 10.1007/s10549-004-9504-2 15528971
35. Thordarson G Slusher N Leong H Ochoa D Rajkumar L Guzman R Nandi S Talamantes F Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-α activation via the mitogen-activated protein kinase pathway Breast Cancer Res 2004, 6:R423-R436. 468665 15217511 10.1186/ bcr812
36. Chlebowski RT Hendrix SL Langer RD Stefanick ML Gass M Lane D Rodabough RJ Gilligan MA Cyr MG Thomson CA Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initiative Randomized Trial JAMA 2003, 289:3243-3253. 10.1001/jama.289.24.3243 12824205
37. Stefanick ML Anderson GL Margolis KL Hendrix SL Rodabough RJ Paskett ED Lane DS Hubbell FA Assaf AR Sarto GE Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy JAMA 2006, 295:1647-1657. 10.1001/ jama.295.14.1647 16609086